NCT04420312View on ClinicalTrials.gov

Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms

CompletedOBSERVATIONAL

Enrollment

1,024

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

April 20, 2020

Study Completion Date

April 20, 2020

Conditions

Pulmonary EmbolismCovid-19

Trial Locations (1)

75014

Groupe Hospitalier Paris Saint-Joseph, Paris

All Listed Sponsors

lead

Fondation Hôpital Saint-Joseph

OTHER

NCT04420312 - Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms | Biotech Hunter | Biotech Hunter